156 related articles for article (PubMed ID: 32428799)
1. Decreased T-cell mediated hepatic injury in concanavalin A-treated PLRP2-deficient mice.
Ge W; Gao Y; Zhao Y; Yang Y; Sun Q; Yang X; Xu X; Zhang J
Int Immunopharmacol; 2020 Aug; 85():106604. PubMed ID: 32428799
[TBL] [Abstract][Full Text] [Related]
2. CD8
Zhang Y; Qi C; Li L; Hua S; Zheng F; Gong F; Fang M
Inflamm Res; 2019 Jan; 68(1):75-91. PubMed ID: 30430216
[TBL] [Abstract][Full Text] [Related]
3. Salecan protected against concanavalin A-induced acute liver injury by modulating T cell immune responses and NMR-based metabolic profiles.
Sun Q; Xu X; Yang X; Weng D; Wang J; Zhang J
Toxicol Appl Pharmacol; 2017 Feb; 317():63-72. PubMed ID: 28109817
[TBL] [Abstract][Full Text] [Related]
4. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
5. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis.
Wolf D; Hallmann R; Sass G; Sixt M; Küsters S; Fregien B; Trautwein C; Tiegs G
J Immunol; 2001 Jan; 166(2):1300-7. PubMed ID: 11145713
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
8. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity.
Alves BN; Leong J; Tamang DL; Elliott V; Edelnant J; Redelman D; Singer CA; Kuhn AR; Miller R; Lowe ME; Hudig D
J Leukoc Biol; 2009 Sep; 86(3):701-12. PubMed ID: 19451396
[TBL] [Abstract][Full Text] [Related]
10. Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes.
Ye XJ; Xu R; Liu SY; Hu B; Shi ZJ; Shi FL; Zeng B; Xu LH; Huang YT; Chen MY; Zha QB; He XH; Ouyang DY
Int Immunopharmacol; 2022 Jan; 102():108380. PubMed ID: 34848154
[TBL] [Abstract][Full Text] [Related]
11. The Role of Serotonin in Concanavalin A-Induced Liver Injury in Mice.
Pang Q; Jin H; Ke X; Man Z; Wang Y; Tan Y; Lu Z; Liu H
Oxid Med Cell Longev; 2020; 2020():7504521. PubMed ID: 31998441
[TBL] [Abstract][Full Text] [Related]
12. Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-κB signaling pathway.
Xue J; Chen F; Wang J; Wu S; Zheng M; Zhu H; Liu Y; He J; Chen Z
Cell Physiol Biochem; 2015; 35(4):1557-70. PubMed ID: 25792514
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
[TBL] [Abstract][Full Text] [Related]
14. Metformin aggravates immune-mediated liver injury in mice.
Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
[TBL] [Abstract][Full Text] [Related]
15. Glutathione peroxidase 1 deficiency attenuates concanavalin A-induced hepatic injury by modulation of T-cell activation.
Lee DH; Son DJ; Park MH; Yoon DY; Han SB; Hong JT
Cell Death Dis; 2016 Apr; 7(4):e2208. PubMed ID: 27124582
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
Fullerton AM; Roth RA; Ganey PE
Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in mice.
Shirin H; Bruck R; Aeed H; Hershkoviz R; Lider O; Kenet G; Avni Y; Halpern Z
Liver; 1997 Dec; 17(6):275-80. PubMed ID: 9455732
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.
Volarevic V; Milovanovic M; Ljujic B; Pejnovic N; Arsenijevic N; Nilsson U; Leffler H; Lukic ML
Hepatology; 2012 Jun; 55(6):1954-64. PubMed ID: 22213244
[TBL] [Abstract][Full Text] [Related]
20. Glt25d2 Knockout Directly Increases CD25+CD69- but Decreases CD25-CD69+ Subset Proliferation and is Involved in Concanavalin-Induced Hepatitis.
Hao X; Liu R; Zhang Y; Li Y; He Q; Huang Y; Jiang Y; Ma J; Li P; Wei H
Cell Physiol Biochem; 2018; 50(3):1186-1200. PubMed ID: 30355948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
